Skip to main content
  • 2017 Acquisition

    Strengthening of the position in Burberry

    Reinforcement of the shareholding in Burberry, from 2.95% at year-end 2016 to 3.95% at end of June 2017, for a market value of EUR 327 million

  • 2017 Acquisition

    Expected performance of KCO III in line with target returns

    At 30 June 2017, Kartesia Credit Opportunities (KCO III) is now fully invested in primary and secondary transactions and has distributed to its investors a total amount of EUR 84 million, representing c.18% of capital called

  • 2017 Acquisition

    Acquisition of Xeris & Ivantis

    • Acquisition by Mérieux Participations II (MP II) of a minority stake in Xeris Pharmaceuticals Inc. : biopharmaceutical company developing injectable therapeutics for  multiple indications including diabetes
    • Acquisition by MP II of a minority stake in Ivantis Inc., a company dedicated to the development of new and innovative solutions for glaucoma

  • 2017 Sale

    Disposal of ELITech

    • ECP III reached an agreement with PAI Partners for the sale of ELITech Group, a manufacturer of specialty in-vitro diagnostics equipment and reagents
    • Estimated net consolidated capital gain on disposal of EUR 102 million (GBL’s share)

  • 2017

    Success of the inaugural institutional bond issue

    • EUR 500 million bond issue, with a coupon of 1.375% and maturing on 23 May 2024
    • Issuance allowing GBL to reinforce its liquidity profile, lengthen the debt maturity profile from 1.3 years at year-end 2016 to 3.5 years at end of June 2017 and further diversify its financing sources by successfully establishing the group’s credit quality on the institutional bond market
    • Oversubscription of almost 3 times by a diversified base of primarily French, Belgian and Anglo-Saxon institutional investors

  • 2017 Acquisition

    Equity investment in Parques Reunidos

    • Acquisition of a 15% position in Parques Reunidos on 12 April 2017, representing a market value of EUR 201 million at end of June 2017
    • Reference operator within the leisure park sector in Europe, North America and Asia, listed on the Madrid stock exchange
    • Representation of GBL in the Board of Directors following the appointment of Colin Hall

  • 2017 Acquisition

    Participation of GBL in the capital increase of Ontex

    In March 2017, GBL participated in the capital increase of Ontex that aims to refinance the company following the acquisition of the “hygienic consumables” activity of Hypermarcas. Following this operation, the holding percentage of GBL remains unchanged at 19.98%. Furthermore, the appointment of Michael Bredael as the GBL representative to the Board of Directors will be proposed to the General Shareholders’ Meeting of Ontex of 24 May.

  • 2017 Acquisition

    Investment in Burberry

    On 28 February 2017, Burberry Group Plc (« Burberry ») announced that GBL had crossed the threshold of 3% of voting rights in the company. The investment in Burberry is aligned with GBL’s portfolio diversification strategy. At 31 March 2017, GBL held 3.0% of the capital of this company, representing a market value of EUR 266 million. Listed on the London Stock Exchange, Burberry has a market capitalisation of around EUR 9 billion at 31 March 2017. Burberry, a luxury British brand, specialises in the design, manufacture and marketing of high-end clothing and accessories. These products are distributed worldwide through its own stores, its website ( and its network of third party retailers. Burberry employs almost 11,000 people and its turnover for the 2015-2016 financial year stood at around GBP 2.5 billion.

  • 2017 Acquisition

    Increase of voting rights in Pernod Ricard

    On 21 February 2017, GBL announced that it holds 10.6% of voting rights in Pernod Ricard (for a stake in capital of 7.5%). This passive crossing of the 10% threshold is the result of the allocation of double voting rights.

  • 2017 Sale

    Sale of the stake in Golden Goose

    In February 2017, ECP III signed an agreement in relation to the disposal of its majority stake in Golden Goose, an Italian designer of contemporary footwear, clothing and accessories. This transaction, completed at the beginning of March 2017, generated a net consolidated capital gain on disposal of EUR 112 million (GBL’s share).

  • 2017 Sale

    Further divestment of ENGIE

    On 7 February 2017, GBL redeemed in cash the balance of the bonds exchangeable into ENGIE shares, i.e. an amount of EUR 306 million. During the first quarter of 2017, GBL also sold the balance of ENGIE shares underlying the bonds exchangeable into ENGIE shares (i.e. 11.9 million shares or 0.5% of the capital for EUR 145 million), generating a consolidated gain of EUR 1 million. GBL’s residual stake in ENGIE therefore stands at 0.1% of the capital at 30 June 2017 (or 2 million shares).

  • 2017 Acquisition

    Acquisition of a stake in Ipackchem by Sagard

    In February 2017, Sagard 3 acquired a stake in Ipackchem, one of the global leaders in the manufacturing of “barrier” packaging, whose products are mainly used in the transport and storage of aromas, fragrances and agrochemical products for which permeability, contamination and evaporation constraints are critical.

  • 2017 Acquisition

    First closing of the new investment fund KCO IV from Kartesia

    In 2016, Kartesia launched a new investment fund (KCO IV) in which Sienna Capital is committed for EUR 150 million. The first closing took place on 22 February 2017. At 31 March 2017, the total fund commitment was EUR 457 million, with a final target of EUR 750 million between now and July 2017.